VCEL
NASDAQ HealthcareVericel Corporation - Common Stock
Biotechnology
📊 Market Data
| Price | $32.11 |
|---|---|
| Volume | 902,547 |
| Market Cap | 1.63B |
| Beta | 1.190 |
| RSI (14-Day) | 18.3 Oversold |
| 200-Day MA | $37.10 |
| 50-Day MA | $36.52 |
| 52-Week High | $48.75 |
| 52-Week Low | $29.24 |
| P/E Ratio | 100.34 |
| Forward P/E | 42.14 |
| Price / Book | 4.58 |
🎯 Investment Strategy Scores
How VCEL scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
21/100
High dividend yield + low volatility
🚀 Moon Shot
81/100
High growth potential (high beta + oversold)
🔪 Falling Knife
85/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
10/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
35/100
Large-cap, institutional-quality stocks
Find VCEL in your text
Paste any text on the homepage — the tool will extract VCEL and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.